We are live on ! Find out more
ACM

Azimuth Capital Management Portfolio holdings

AUM $2.34B
1-Year Est. Return 16.67%
This Fund
S&P 500
This Quarter Est. Return
+5.43%
1 Year Est. Return
+16.67%
3 Year Est. Return
+80.26%
5 Year Est. Return
+136.66%
10 Year Est. Return
AUM
$727M
AUM Growth
+$160M
Cap. Flow
+$132M
Cap. Flow %
18.17%
Top 10 Hldgs %
20.78%
Holding
255
New
32
Increased
149
Reduced
56
Closed
6

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$4.59M
2
XOM icon
ExxonMobil
XOM
+$4.36M
3
SLB icon
SLB Ltd
SLB
+$4.33M
4
MRK icon
Merck
MRK
+$4.25M
5
GE icon
GE Aerospace
GE
+$4.23M

Sector Composition

Rank Sector Weight
1 Healthcare 19.93%
2 Industrials 12.78%
3 Consumer Staples 12.68%
4 Technology 12.35%
5 Financials 7.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVS icon
26
CVS Health
CVS
$137B
$6.51M 0.9%
114,763
+210
+0.2% +$12.5K
MCK icon
27
McKesson
MCK
$99.5B
$6.49M 0.89%
50,608
-105
-0.2% -$12.9K
RMD icon
28
ResMed
RMD
$29.5B
$6.37M 0.88%
120,600
+33,900
+39% +$1.64M
TSS
29
DELISTED
Total System Services, Inc.
TSS
$6.01M 0.83%
204,360
+131,145
+179% +$3.62M
HSY icon
30
Hershey
HSY
$36.6B
$5.87M 0.81%
63,450
+2,655
+4% +$248K
UNP icon
31
Union Pacific
UNP
$178B
$5.84M 0.8%
75,190
-950
-1% -$75.1K
CL icon
32
Colgate-Palmolive
CL
$73.6B
$5.77M 0.79%
97,285
+21,290
+28% +$1.26M
CSCO icon
33
Cisco
CSCO
$452B
$5.71M 0.79%
243,893
+20,680
+9% +$513K
CELG
34
DELISTED
Celgene Corp
CELG
$5.69M 0.78%
73,844
-2,526
-3% -$177K
BLK icon
35
Blackrock
BLK
$165B
$5.63M 0.77%
20,820
-100
-0.5% -$27.2K
DUK icon
36
Duke Energy
DUK
$100B
$5.63M 0.77%
84,332
+23,573
+39% +$1.61M
SLB icon
37
SLB Ltd
SLB
$76.5B
$5.4M 0.74%
61,072
+52,675
+627% +$4.33M
BAX icon
38
Baxter International
BAX
$12.1B
$5.32M 0.73%
149,139
+24,200
+19% +$939K
BIIB icon
39
Biogen
BIIB
$29.5B
$5.28M 0.73%
21,939
+139
+0.6% +$31.1K
DD
40
DELISTED
Du Pont De Nemours E I
DD
$5.26M 0.72%
94,670
+1,474
+2% +$80.5K
MDLZ icon
41
Mondelez International
MDLZ
$77.9B
$5.24M 0.72%
166,796
+29,485
+21% +$915K
GD icon
42
General Dynamics
GD
$105B
$5.11M 0.7%
58,365
+49,715
+575% +$4.22M
VOD icon
43
Vodafone
VOD
$36.4B
$5.07M 0.7%
141,404
+35,738
+34% +$1.13M
WBA
44
DELISTED
Walgreens Boots Alliance
WBA
$5M 0.69%
92,960
+34,400
+59% +$1.73M
EMR icon
45
Emerson Electric
EMR
$83.6B
$4.9M 0.67%
75,777
+21,800
+40% +$1.33M
LLY icon
46
Eli Lilly
LLY
$1.07T
$4.88M 0.67%
97,064
+39,973
+70% +$2.09M
RTX icon
47
RTX Corp
RTX
$294B
$4.88M 0.67%
71,855
+302
+0.4% +$19.8K
KRFT
48
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
$4.87M 0.67%
92,837
-12,423
-12% -$680K
AAPL icon
49
Apple
AAPL
$4.95T
$4.73M 0.65%
277,928
+14,056
+5% +$233K
PRAA icon
50
PRA Group
PRAA
$683M
$4.73M 0.65%
78,855
-1,110
-1% -$59.5K

Similar funds

Azimuth Capital Management's Q3 2013 Portfolio in Review

As of Q3 2013, Azimuth Capital Management held 255 positions worth $727M, up 28% from $567M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Azimuth Capital Management deployed $132M of net new capital in Q3 2013, opening 32 new positions and adding to 149 existing holdings. Its largest new stake was Broadcom: 1,016,200 shares worth $4.38M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Consumer Staples.

On the sell side, the largest reduction was TOWERS WATSON & CO COM STK CL A (DE), an estimated $3.05M trimmed.

  • Azimuth Capital Management's largest Q3 2013 buy was Broadcom: 1,016,200 shares worth $4.38M.
  • Azimuth Capital Management added most to Pfizer in Q3 2013, an estimated $4.59M increase.
  • Azimuth Capital Management's biggest Q3 2013 reduction was TOWERS WATSON & CO COM STK CL A (DE), cutting an estimated $3.05M.
  • Azimuth Capital Management fully exited Intuitive Surgical in Q3 2013, selling an estimated $2.48M.
  • Azimuth Capital Management's ten largest holdings make up 21% of its $727M portfolio in Q3 2013.
  • Azimuth Capital Management opened 32 new positions and closed 6 in Q3 2013.
  • Azimuth Capital Management's portfolio value rose 28% quarter-over-quarter to $727M.

Based on Azimuth Capital Management's 13F filing for Q3 2013, filed 30 Oct 2013.